Evidence map›Paper›PMID 40989361›Full record

ArticlePeerJ. Computer science2025

Hybrid deep layered network model based on multi-scale feature extraction and deep feature optimization for acute lymphoblastic leukemia anomaly detection.

Gökalp Çınarer

Abstract read
In one paragraph

Article in PeerJ. Computer science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Gökalp ÇınarerComputer Engineering, Yozgat Bozok University, Yozgat, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute lymphoblastic leukemia (ALL), one of the common diseases of our day, is one of the most common hematological malignant diseases in childhood. Early diagnosis of ALL, which plays a critical role in medical diagnosis processes, is of great importance especially for the effective management of the treatment process of cancer patients. Therefore, ALL cells must be detected and classified correctly. Traditional methods used today prolong the detection and classification processes of cells, cause hematologists to interpret them according to their expertise, and delay medical decision-making processes. In this study, the performance of the hybrid model developed with different deep learning models for ALL diagnosis was comparatively analyzed. In the proposed ALL detection architecture, blood cell images were processed using the center-based cropping strategy and irrelevant areas in the images were automatically removed. The dataset was divided into training, validation, and test sets, and then features were extracted with deep hyperparameters for convolution, pooling, and activation layers using a model based on Xception architecture. The obtained features were optimized to the advanced Extreme Gradient Boosting (XGBoost) classifier and model classification results were obtained. The results showed that the proposed model achieved 98.88% accuracy. This high accuracy rate was compared with different hybrid models and it was seen that the model was more successful in detecting ALL disease compared to existing studies.

Indexed as

ALL detectionConvolutional neural network (CNN)Deep learningHybrid deep learningMachine learningTransfer learning

Identifiers

PMID40989361
PMCPMC12453709

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.